Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

CareDx director Richard Riggsbee sells $395,137 in shares

CareDx's director, Richard Riggsbee, divested a considerable sum of $395,137 worth of shares on November 16, 2026, adhering to a pre-established Rule 10b5-1 trading plan initiated on August 4, 2026. The stock price at the time of sale was $74.44, having surged 366% over the previous year. However, InvestingPro's analysis indicates the stock is overvalued compared to its intrinsic value.

Mr. Riggsbee sold a total of 5,285 shares in four separate transactions, each with weighted average prices ranging from $74.0181 to $77.0225. The sales saw individual share prices between $73.39 and $77.45. Post-sale, Riggsbee held 34,027 shares directly. Despite these transactions, CareDx has reported robust third-quarter 2026 earnings, trumping expectations with a $0.70 adjusted profit per share versus an anticipated $0.26.

Revenue reached $139 million, surpassing the projected $121.95 million. Consequently, the company has adjusted its full-year guidance, signaling optimism about its ongoing performance. Analysts have also shown increased confidence, with Piper Sandler and BTIG raising their price targets to $100 and $92, respectively, while Canaccord enhanced its target to $99. These actions reflect a bullish outlook on CareDx's potential growth.

Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at investing.com →

More in Finance & Markets

More from Thursday 19 November →